Skip to main content
. 2009 Oct 5;27(32):5425–5430. doi: 10.1200/JCO.2009.22.6688

Fig 1.

Fig 1.

Treatment regimen. Pentostatin (P) was administered weekly for 4 weeks, then every 2 weeks for up to 14 doses. After the initial 3-day dose escalation, alemtuzumab (A) was administered three times weekly for up to 3 months. D, day; W, week.